Envision Healthcare Sets Earnings Release and Conference Call Dates for First Quarter 2018 Results

NEXT STORY
Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance
PREV STORY
G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rafael Pharmaceuticals Receives FDA Fast Track Designation for CPI-613® (devimistat) for the Treatment of Acute Myeloid Leukemia (AML)

author_avatar
NASDAQ Market News

FibroGen Presents Phase 3 Efficacy and Safety Results for Roxadustat Versus Epoetin Alfa as Treatment of Anemia in Incident Dialysis Patients with Chronic Kidney Disease

author_avatar
NASDAQ Market News

Global Anti-VEGF Antibodies Market to 2022: Roche, Novartis, Sanofi, Regeneron, Bayer & AstraZeneca Dominate the $100 Billion Market

Dublin, Aug. 09, 2018 (GLOBE NEWSWIRE) -- The "Anti-VEGF Antibodies: Global Technology Assessment, Market ...

author_avatar
NASDAQ Market News